Mineo Kurokawa

Mineo Kurokawa

Auto-generated profile, based on publicly available information

Mineo Kurokawa

Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2002 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
YMYutaka Midorikawa
Yutaka Midorikawa
SIShumpei Ishikawa
Shumpei Ishikawa
HIHiroko Iwanari
Hiroko Iwanari
TITakeshi Imamura
Takeshi Imamura
HSHirohiko Sakamoto
Hirohiko Sakamoto
HAHiroyuki Aburatani
Hiroyuki Aburatani
The Glypican (GPC) family is a prototypical member of the cell‐surface heparan sulfate proteoglycans (HSPGs). The HSPGs have been demonstrated to interact with growth factors, act as coreceptors and modulate growth factor activity. Here we show that based on oligonucleotide array analysis, GPC3 was upregulated in hepatocellular carcinoma (HCC). By northern blot analysis, GPC3 mRNA was found to be upregulated in 29 of 52 cases of HCC (55.7%). By Western blot analysis carried out with a monoclonal anti‐GPC3 antibody we generated, the GPC3 protein was found to be overexpressed in 6 hepatoma cell lines, HepG2, Hep3B, HT17, HuH6, HuH7 and PLC/PRF/5, as well as 22 tumors (42.3%). To investigate the role of overexpressed GPC3 in liver cancer, we analyzed its effects on cell growth of hepatoblastoma‐derived cells. Overexpression of GPC3 modulated cell proliferation by inhibiting fibroblast growth factor 2 (FGF2) and bone morphogenetic protein 7 (BMP‐7) activity. An interaction of GPC3 and FGF2 was revealed by co‐immunoprecipitation, while GPC3 was found to inhibit BMP‐7 signaling through the Smad pathway by reporter gene assay. The modulation of growth factors by GPC3 may help explain its role in liver carcinogenesis. In addition, the ability of HCC cells to express GPC3 at high levels may serve as a new tumor marker for HCC.

4 April 2006 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
HYHisayo Yamaoka
Hisayo Yamaoka
HAHirotaka Asato
Hirotaka Asato
TOToru Ogasawara
Toru Ogasawara
SNSatoru Nishizawa
Satoru Nishizawa
TTTsuguharu Takahashi
Tsuguharu Takahashi
KHKazuto Hoshi
Kazuto Hoshi

12 February 2014 in WIREs RNA
Verified
Journal Article
Closed access
PDF file
KYKenichi Yoshida
Kenichi Yoshida
SOSeishi Ogawa
Seishi Ogawa

22 March 2004 in Liver Transplantation
Verified
Journal Article
Open access
PDF file
YSYasuhiko Sugawara
Yasuhiko Sugawara
MMMasatoshi Makuuchi
Masatoshi Makuuchi
NANobuhisa Akamatsu
Nobuhisa Akamatsu
YKYoji Kishi
Yoji Kishi
TNTakashi Niiya
Takashi Niiya
NKNorihiro Kokudo
Norihiro Kokudo
Short and direct vein anastomosis is generally performed in living donor liver transplantation using a right liver graft. The graft will regenerate, however, and might thus compress the anastomosis. We formulated a strategy for outflow reconstruction in right liver graft. When reconstruction of multiple short hepatic veins was necessary, a cryopreserved inferior vena cava graft was anastomosed with the hepatic veins of the graft in a basin. When there were no major short hepatic veins in the graft, a rectangular-shaped vein graft was used to make a single orifice using the middle and right hepatic veins in the graft. When there were no tributaries of the middle hepatic vein to be reconstructed, a diamond-shaped vein patch was anastomosed on the anterior wall of the right hepatic vein orifice of the graft. These techniques were satisfactorily applied in 40 patients with no torsion or tension at the anastomotic site of the hepatic venous reconstruction or other complications in outflow. The present strategy seemed to be technically feasible for outflow reconstruction in a right liver graft. (Liver Transpl 2004;10:541-547.)

20 December 2002 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
SOShingo Okabe
Shingo Okabe
YUYoshikazu Ugawa
Yoshikazu Ugawa
IKIchiro Kanazawa
Ichiro Kanazawa
EGEffectiveness of rTMS on Parkinson's Disease Study Group
Effectiveness of rTMS on Parkinson's Disease Study Group

20 January 2010 in Journal of Comparative Neurology
Verified
Journal Article
Closed access
PDF file
KKKenji Kondo
Kenji Kondo
KSKeigo Suzukawa
Keigo Suzukawa
TSTakashi Sakamoto
Takashi Sakamoto
KWKenta Watanabe
Kenta Watanabe
KKKaori Kanaya
Kaori Kanaya
TYTatsuya Yamasoba
Tatsuya Yamasoba